Precision Medicine Market Size, Share, By Type (Diagnostics, Therapeutics, and Others), Technology (Bioinformatics, Drug Discovery, Gene Sequencing, Precision Molecular Diagnostics, Big Data Analytics, and Others), Application (Oncology, CNS, Respiratory, Immunology, Hematology, and Others), End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, and Others), and Region - Trends, Analysis, and Forecast till 2035

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America is the region dominating the precision medicine market share by 53.9%. This is due to this region’s large investment in research and development, efficient healthcare system, acceptance of new technologies, high prevalence of chronic diseases, prominent academic and research institutions, and presence of major diagnostic companies.

Europe is the region with the fastest growing CAGR, during the forecast period. This is due to this region’s, significant advancements in biomarker testing, robust healthcare infrastructure, high research and development activity, high healthcare spending, and a large presence of key precision medicine players.